Abstract
Scaffolds with three-dimensional, customizable architectures will be fabricated and populated with fibroblasts via automated processes of a Fused Deposition Modeling BioPrinter. The success of the design will be dependent on the accuracy of fabrication and adhesion/proliferation of the seeded fibroblasts.